Profile data is unavailable for this security.
About the company
Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company. It is commercializing advanced products to address unmet needs in women’s sexual and reproductive health. Its first FDA-approved product, Phexxi (lactic acid, citric acid, and potassium bitartrate), is a hormone-free, on-demand prescription contraceptive vaginal gel. It comes in a box of 12 pre-filled applicators and is applied 0-60 minutes before each act of sex. Phexxi is an advanced gel that works to prevent pregnancy without the use of hormones. Phexxi prevents pregnancy by reducing sperm motility, inhibiting sperm from reaching the ovum to form a zygote. Phexxi is designed to address underserved and unmet needs in the birth control market. Using its platform, women can have a telehealth visit with a health care provider to determine their eligibility for a Phexxi prescription. It is also focused on commercializing SOLOSEC (secnidazole) 2g oral granules that address two pervasive sexual health infections.
- Revenue in USD (TTM)17.71m
- Net income in USD57.36m
- Incorporated2007
- Employees37.00
- LocationEvofem Biosciences Inc12400 High Bluff Drive, Suite 600SAN DIEGO 92130United StatesUSA
- Phone+1 (858) 550-1900
- Fax+1 (302) 636-5454
- Websitehttps://www.evofem.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ITonis Inc | 0.00 | -1.17m | 609.36k | -- | -- | -- | -- | -- | -0.0012 | -0.0012 | 0.00 | -0.0004 | 0.00 | -- | -- | -- | -187.63 | -- | -1,169.36 | -- | -- | -- | -- | -- | -- | -0.8999 | -- | -- | -- | -- | -506.86 | -- | -- | -- |
| TRACON Pharmaceuticals Inc | 3.20m | 5.20m | 707.07k | 17.00 | 0.0547 | -- | 0.1357 | 0.221 | 3.79 | 3.79 | 1.39 | -0.9065 | 0.3267 | -- | -- | 188,235.30 | 53.04 | -79.42 | -- | -177.85 | -- | -- | 162.34 | -813.81 | -- | -19.35 | -- | -- | -- | 32.05 | 87.68 | -- | -- | -- |
| Resonate Blends Inc | 751.28k | -1.88m | 797.05k | 6.00 | -- | -- | -- | 1.06 | -0.0205 | -0.0205 | 0.0083 | -0.0244 | 0.632 | -- | 11.93 | -- | -158.40 | -680.29 | -- | -- | 46.92 | -78.88 | -250.64 | -12,895.26 | -- | -2.30 | 4.00 | -- | -66.73 | -56.57 | -316.63 | -- | -- | -- |
| PainReform Ltd | 0.00 | -17.67m | 881.21k | 6.00 | -- | -- | -- | -- | -41.92 | -41.92 | 0.00 | -3.53 | 0.00 | -- | -- | 0.00 | -309.43 | -55.47 | -650.22 | -68.20 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -6.28 | -- | -- | -- |
| Agentix Corp | 0.00 | -585.16k | 906.02k | -- | -- | -- | -- | -- | -0.0146 | -0.0146 | 0.00 | -0.0639 | 0.00 | -- | -- | -- | -318.23 | -- | -- | -- | -- | -- | -- | -- | -- | -19.24 | -- | -- | -- | -- | 57.41 | -- | -- | -- |
| Bespoke Extracts Inc | 956.86k | -1.36m | 966.01k | 10.00 | -- | -- | -- | 1.01 | -0.1331 | -0.1331 | 0.0941 | -0.194 | 2.29 | 20.10 | 21.36 | 95,686.00 | -325.13 | -- | -- | -- | 45.50 | -- | -141.75 | -- | 0.0482 | -53.38 | -- | -- | 22,933.72 | -- | 63.98 | -- | -- | -- |
| Evofem Biosciences Inc | 17.71m | 57.36m | 973.19k | 37.00 | 0.0007 | -- | 0.0169 | 0.0549 | -0.4918 | -0.4918 | 0.0297 | -0.7803 | 1.57 | 1.81 | 3.61 | 478,756.80 | 534.21 | -211.64 | -- | -- | 75.75 | -- | 341.16 | -1,031.55 | 0.0841 | -4.50 | -- | -- | 8.20 | -- | 164.08 | -- | -10.59 | -- |
| CanaQuest Medical Corp | 0.00 | -812.13k | 1.05m | -- | -- | -- | -- | -- | -0.0517 | -0.0517 | 0.00 | -0.0372 | 0.00 | -- | -- | -- | -1,084.38 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 57.42 | -- | -- | -- |
| Gold River Productions Inc. | -100.00bn | -100.00bn | 1.37m | 1.00k | -- | 2.12 | -- | -- | -- | -- | -- | 0.0005 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -100.11 | -- | -- | -- |
| 60 Degrees Pharmaceuticals Inc | 441.25k | -2.03m | 1.38m | 3.00 | 1.43 | -- | -- | 3.12 | 0.9455 | 0.9455 | 0.6336 | 2.98 | 0.0755 | 0.8355 | 2.09 | 147,083.30 | -27.71 | -- | -- | -- | 15.59 | -- | -366.89 | -- | 2.74 | -- | 0.0505 | -- | -50.40 | -- | 35.51 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Pennsylvania State Employees' Retirement Systemas of 31 Dec 2021 | 0.00 | 0.00% |
| Heights Capital Management, Inc.as of 31 Dec 2023 | 0.00 | 0.00% |
